Nebenwirkungen · Rozlytrek
Rozlytrek 50 mg film-coated granules in sachet · Abschnitt 4.8 · PDF-Seite 43
HOS-143063 · Präparat HOS-098918
The most common adverse reactions (≥20%) were fatigue, constipation, diarrhoea, dizziness, dysgeusia, oedema, increased weight, anaemia, increased blood creatinine, nausea, dysaesthesia, pain, vomiting, pyrexia, arthralgia, increased aspartate aminotransferase and dyspnoea, cognitive disorders, cough, and increased alanine aminotransferase. The most frequent serious adverse reactions (≥2%) were lung infection (5.3%), fractures (4.1%), dyspnoea (3.6%), cognitive impairment (2.9%), pleural effusion (2.5%) and pyrexia (2.5%). Permanent discontinuation due to an adverse reaction occurred in 6.0% of patients.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-03-27T15:44:00Z · SHA-256 dd56cb496d4ec02972235ebd05e62294b444e36302865842fe46e147734ef2b5 · Passage 4c854114280f7f756f2e1e89f74a4720f9cb3df29b9796a8297a25d13cad5f51 · Zeichen 31–642 im Abschnitt